Phase 3 Study Compares Hepatitis B Vaccine Doses in Older Patients With T2D
For older patients with type 2 diabetes mellitus, higher levels of seroprotection against the hepatitis B virus were obtained following the receipt of the 2-dose vaccine vs the 3-dose vaccine.
